PROTARA THERAPEUTICS INC's ticker is TARA and the CUSIP is 74365U107. A total of 48 filers reported holding PROTARA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $349,409 | +69781.8% | 209,227 | 0.0% | 0.02% | -17.4% |
| Q2 2023 | $500 | -23.7% | 209,227 | 0.0% | 0.02% | -28.1% |
| Q1 2023 | $655 | -99.9% | 209,227 | 0.0% | 0.03% | +6.7% |
| Q4 2022 | $560,728 | -9.4% | 209,227 | 0.0% | 0.03% | -14.3% |
| Q3 2022 | $619,000 | +1.0% | 209,227 | 0.0% | 0.04% | -10.3% |
| Q2 2022 | $613,000 | -42.7% | 209,227 | 0.0% | 0.04% | -29.1% |
| Q1 2022 | $1,069,000 | -24.3% | 209,227 | 0.0% | 0.06% | 0.0% |
| Q4 2021 | $1,412,000 | -2.5% | 209,227 | 0.0% | 0.06% | +7.8% |
| Q3 2021 | $1,448,000 | -28.9% | 209,227 | 0.0% | 0.05% | -29.2% |
| Q2 2021 | $2,038,000 | -38.1% | 209,227 | 0.0% | 0.07% | -35.7% |
| Q1 2021 | $3,293,000 | -35.0% | 209,227 | 0.0% | 0.11% | -31.3% |
| Q4 2020 | $5,065,000 | +43.9% | 209,227 | 0.0% | 0.16% | +33.6% |
| Q3 2020 | $3,521,000 | – | 209,227 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,674,031 | $13,664,000 | 4.24% |
| Ikarian Capital, LLC | 296,426 | $1,515,000 | 0.20% |
| DLD Asset Management, LP | 229,531 | $1,173,000 | 0.07% |
| Orbimed Advisors | 830,641 | $4,245,000 | 0.07% |
| Boxer Capital, LLC | 209,227 | $1,069,000 | 0.06% |
| Perceptive Advisors | 383,526 | $1,960,000 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 64,000 | $327,000 | 0.01% |
| Baker Brothers Advisors | 199,671 | $1,020,000 | 0.01% |
| Trexquant Investment LP | 16,313 | $83,000 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 27,591 | $141,000 | 0.00% |